| A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease A Nordberg, C Ballard, R Bullock, T Darreh-Shori, M Somogyi The primary care companion for CNS disorders 15 (2), 26731, 2013 | 340 | 2013 |
| Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months T Darreh–Shori, O Almkvist, ZZ Guan, A Garlind, B Strandberg, ... Neurology 59 (4), 563-572, 2002 | 207 | 2002 |
| Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with … A Kadir, A Marutle, D Gonzalez, M Schöll, O Almkvist, M Mousavi, ... Brain 134 (1), 301-317, 2011 | 180 | 2011 |
| Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device H Eyjolfsdottir, M Eriksdotter, B Linderoth, G Lind, B Juliusson, P Kusk, ... Alzheimer's research & therapy 8, 1-11, 2016 | 141 | 2016 |
| Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent … T Darreh-Shori, H Soininen Current Alzheimer Research 7 (1), 67-73, 2010 | 131 | 2010 |
| Characterization of the human FLICE‐inhibitory protein locus and comparison of the anti‐apoptotic activity of four different flip isoforms M Djerbi, T Darreh‐Shori, B Zhivotovsky, A Grandien Scandinavian journal of immunology 54 (1‐2), 180-189, 2001 | 114 | 2001 |
| Long‐lasting acetylcholinesterase splice variations in anticholinesterase‐treated Alzheimer's disease patients T Darreh‐Shori, E Hellström‐Lindahl, C Flores‐Flores, ZZ Guan, H Soreq, ... Journal of neurochemistry 88 (5), 1102-1113, 2004 | 113 | 2004 |
| Regulated extracellular choline acetyltransferase activity—the plausible missing link of the distant action of acetylcholine in the cholinergic anti-inflammatory pathway S Vijayaraghavan, A Karami, S Aeinehband, H Behbahani, A Grandien, ... PloS one 8 (6), e65936, 2013 | 110 | 2013 |
| Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor D Ferreira, E Westman, H Eyjolfsdottir, P Almqvist, G Lind, B Linderoth, ... Journal of Alzheimer’s disease 43 (3), 1059-1072, 2014 | 107 | 2014 |
| PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD A Kadir, T Darreh-Shori, O Almkvist, A Wall, M Grut, B Strandberg, ... Neurobiology of aging 29 (8), 1204-1217, 2008 | 101 | 2008 |
| Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients A Nordberg, T Darreh-Shori, E Peskind, H Soininen, M Mousavi, G Eagle, ... Current Alzheimer Research 6 (1), 4-14, 2009 | 95 | 2009 |
| Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer’s disease following chronic donepezil … T Darreh-Shori, L Meurling, T Pettersson, K Hugosson, ... Journal of neural transmission 113, 1791-1801, 2006 | 79 | 2006 |
| Safety of lumbar puncture procedures in patients with Alzheimer's disease E Peskind, A Nordberg, T Darreh-Shori, H Soininen Current Alzheimer Research 6 (3), 290-292, 2009 | 76 | 2009 |
| Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo T Darreh-Shori, A Forsberg, N Modiri, N Andreasen, K Blennow, C Kamil, ... Neurobiology of aging 32 (12), 2320. e15-2320. e32, 2011 | 75 | 2011 |
| Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine T Darreh-Shori, A Kadir, O Almkvist, M Grut, A Wall, G Blomquist, ... Neurobiology of Aging 29 (2), 168-184, 2008 | 73 | 2008 |
| Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease R Lane, HH Feldman, J Meyer, Y He, SH Ferris, A Nordberg, ... Pharmacogenetics and genomics 18 (4), 289-298, 2008 | 72 | 2008 |
| Changes in brain 11C–nicotine binding sites in patients with mild Alzheimer’s disease following rivastigmine treatment as assessed by PET A Kadir, T Darreh-Shori, O Almkvist, A Wall, B Långström, A Nordberg Psychopharmacology 191, 1005-1014, 2007 | 72 | 2007 |
| Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease A Karami, H Eyjolfsdottir, S Vijayaraghavan, G Lind, P Almqvist, A Kadir, ... Alzheimer's & Dementia 11 (11), 1316-1328, 2015 | 71 | 2015 |
| Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease T Darreh-Shori, S Vijayaraghavan, S Aeinehband, F Piehl, RPF Lindblom, ... Neurobiology of aging 34 (11), 2465-2481, 2013 | 68 | 2013 |
| Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme—a plausible missing link for their association with incidence … R Kumar, A Kumar, A Nordberg, B Långström, T Darreh‐Shori Alzheimer's & Dementia 16 (7), 1031-1042, 2020 | 67 | 2020 |
Bengt LinderothProfessor em. Functional Neurosurgery, Dept. Clinical Neuroscience, Karolinska Institutet, StockholmVerified email at ki.se